VVM
Versant Venture Management Portfolio holdings
AUM
$82.1M
This Quarter Return
+32.61%
1 Year Return
-26.22%
3 Year Return
+73.87%
5 Year Return
-1.11%
10 Year Return
+1,578.11%
AUM
$89.7M
AUM Growth
+$89.7M
(-9.1%)
Cap. Flow
-$46M
Cap. Flow
% of AUM
-51.31%
Top 10 Holdings %
Top 10 Hldgs %
100%
Holding
7
New
2
Increased
–
Reduced
1
Closed
–
Top Buys
| 1 |
BOLD
Audentes Therapeutics, Inc
BOLD
|
$32.2M |
| 2 |
IMDZ
Immune Design Corp.
IMDZ
|
$16.7M |
Top Sells
| 1 |
Glaukos
GKOS
|
$94.9M |
Sector Composition
| 1 | Healthcare | 74.5% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
BOLD
1
DELISTED
Audentes Therapeutics, Inc
BOLD
| $32.2M | 35.88% | +1,806,832 | New | +$32.2M |
|
|
IMDZ
2
DELISTED
Immune Design Corp.
IMDZ
| $16.7M | 18.66% | +2,208,210 | New | +$16.7M |
|
3
Ocular Therapeutix
OCUL
$2.12B
| $15.2M | 16.97% | 2,215,384 | – | – |
|
|
CLVS
4
DELISTED
Clovis Oncology, Inc.
CLVS
| $14.7M | 16.38% | 407,416 | – | – |
|
|
AKAO
5
DELISTED
Achaogen, Inc.
AKAO
| $6.14M | 6.84% | 1,281,152 | – | – |
|
|
6
Glaukos
GKOS
$5.5B
| $2.7M | 3.01% | 71,428 -2,515,557 | -97% | -$94.9M |
|
|
CBAY
7
DELISTED
Cymabay Therapeutics
CBAY
| $2.03M | 2.27% | 1,048,601 | – | – |
|